title: The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2.
abstract: The Agr quorum-sensing system represents the master regulator for staphylococcal virulence factors and is known to have a strong impact on the release of pathogen-associated molecular pattern (PAMP) molecules. Among the various staphylococcal PAMPs, phenol-soluble modulin (PSM) peptides have attracted increasing interest because they are crucial for staphylococcal virulence and have neutrophil-recruiting properties. The latter depend on recognition of PSMs by the neutrophil formyl peptide receptor 2 (FPR2/ALX), for which PSMs are highly efficient agonists. We demonstrate that Agr inactivation in Staphylococcus aureus or S. epidermidis leads to strongly reduced neutrophil responses, which is in agreement with the previously reported strict control of PSM expression by Agr. Agr had a distinct and profound impact on activation of FPR2/ALX but not of the related FPR1 receptor that senses bacterial formylated peptides. S. epidermidis PSMs had similar FPR2/ALX-activating properties but differed in their dependence on N-terminal formylation compared to S. aureus PSMs. Moreover, S. aureus and S. epidermidis PSMs upregulated the neutrophil complement receptor CD11b via FPR2/ALX stimulation in an Agr-dependent fashion. Hence, Agr controls the capacity of staphylococcal pathogens to activate FPR2/ALX-dependent neutrophil responses, underscoring the crucial role of FPR2/ALX and PSMs in staphylococcus-host interaction.
authors: Cellular and Molecular Microbiology Division, Interfaculty Institute for Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
authors: Dorothee
authors: D
authors: Kretschmer
authors: Nele
authors: N
authors: Nikola
authors: Manuela
authors: M
authors: Dürr
authors: Michael
authors: M
authors: Otto
authors: Andreas
authors: A
authors: Peschel
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000276:immunology / Q000378:metabolism; D001426:Bacterial Proteins / Q000276:immunology* / Q000378:metabolism; D002460:Cell Line; D054884:Host-Pathogen Interactions / Q000276:immunology; D006801:Humans; D009504:Neutrophils / Q000276:immunology* / Q000378:metabolism; D044042:Receptors, Formyl Peptide / Q000276:immunology* / Q000378:metabolism; D044067:Receptors, Lipoxin / Q000276:immunology* / Q000378:metabolism; D013203:Staphylococcal Infections / Q000276:immunology / Q000378:metabolism; D013211:Staphylococcus aureus / Q000276:immunology* / Q000378:metabolism / Q000472:pathogenicity; D013212:Staphylococcus epidermidis / Q000276:immunology* / Q000378:metabolism / Q000472:pathogenicity; D015534:Trans-Activators / Q000276:immunology* / Q000378:metabolism; D014774:Virulence
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C095698:Agr protein, Staphylococcus aureus; D001426:Bacterial Proteins; C105101:FPR2 protein, human; C442142:HSH2D protein, human; D044042:Receptors, Formyl Peptide; D044067:Receptors, Lipoxin; D015534:Trans-Activators